EUROPE STEM CELL ASSAY MARKET FORECAST 2017-2025
KEY FINDINGS
The Europe stem cell assay market is expected to grow $793 million by 2025. The market growth is expected at the CAGR of 21.49% in the forecast period. The base year considered for the market study is 2016. Rise in the adoption of stem cell assay, the evolvement of technology and increase spending in the stem cell assay market are the key drivers in the Europe stem cell assay market.
MARKET INSIGHTS
The Europe stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user and geography. The Europe stem cell assay market by type is segmented into cell viability and toxicity assays, isolation and purification assays, cell identification assays, cell differentiation assays, cell function assays and cell apoptosis assays. The product of Europe stem cell assay market is segmented into instruments and detection kits. The kits of stem cell assay market are further segmented into adult stem cell kits, human embryonic stem cell kit. The stem cell market by application is further bifurcated into regenerative medicine and therapy development, drug discovery and development and clinical research market. The end-user of stem cell market is segmented into research institutes and industry research. The Europe stem cell assay market by geography is segmented into UK, France, Germany, Spain, Italy and rest of Europe. Increasing Adoption of Stem Cell Assay, improvement in the Technology, high expense in Stem Cell Research are the major drivers for the market growth in Europe region. The rise in the adoption of stem cell assay for drug screening & testing is one of the major reasons driving the industry research
The Europe stem cell assay market is expected to grow $793 million by 2025. The market growth is expected at the CAGR of 21.49% in the forecast period. The base year considered for the market study is 2016. Rise in the adoption of stem cell assay, the evolvement of technology and increase spending in the stem cell assay market are the key drivers in the Europe stem cell assay market.
MARKET INSIGHTS
The Europe stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user and geography. The Europe stem cell assay market by type is segmented into cell viability and toxicity assays, isolation and purification assays, cell identification assays, cell differentiation assays, cell function assays and cell apoptosis assays. The product of Europe stem cell assay market is segmented into instruments and detection kits. The kits of stem cell assay market are further segmented into adult stem cell kits, human embryonic stem cell kit. The stem cell market by application is further bifurcated into regenerative medicine and therapy development, drug discovery and development and clinical research market. The end-user of stem cell market is segmented into research institutes and industry research. The Europe stem cell assay market by geography is segmented into UK, France, Germany, Spain, Italy and rest of Europe. Increasing Adoption of Stem Cell Assay, improvement in the Technology, high expense in Stem Cell Research are the major drivers for the market growth in Europe region. The rise in the adoption of stem cell assay for drug screening & testing is one of the major reasons driving the industry research
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. UNITED STATES IS THE FASTEST GROWING STEM CELL ASSAY MARKET
3.2.2. INDUSTRY RESEARCH IS THE LEADING END-USER SEGMENT
3.2.3. DEMAND FOR REGENERATIVE MEDICINE
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. RISING ADOPTION OF STEM CELL ASSAY
4.1.2. IMPROVEMENT IN TECHNOLOGY
4.1.3. SPENDING IN STEM CELL RESEARCH
4.2. MARKET RESTRAINTS
4.2.1. HIGH COST FOR TREATMENT
4.2.2. SLOW RESPONSE TIME OF REGULATORY BODIES
4.3. MARKET OPPORTUNITIES
4.3.1. CHANGING MARKET DYNAMICS
4.4. MARKET CHALLENGES
4.5. ISSUE IN THE PATIENT’S IMMUNE SYSTEM
5. MARKET SEGMENTATION
5.1. BY TYPES OF ASSAY
5.1.1. CELL VIABILITY & TOXICITY ASSAYS
5.1.2. ISOLATION/PURIFICATION ASSAYS
5.1.3. CELL IDENTIFICATION ASSAYS
5.1.4. CELL DIFFERENTIATION ASSAYS
5.1.5. CELL FUNCTION ASSAYS
5.1.6. CELL APOPTOSIS ASSAYS
5.2. BY PRODUCT
5.2.1. INSTRUMENTS
5.2.2. DETECTION KITS
5.3. BY KITS
5.3.1. ADULT STEM CELL KITS
5.3.1.1. MESENCHYMAL STEM CELL KITS
5.3.1.2. INDUCED PLURIPOTENT STEM CELL KITS
5.3.1.3. HEMATOPOIETIC STEM CELL KITS
5.3.1.4. NEURONAL STEM CELLS KITS
5.3.1.5. UMBILICAL CORD STEM CELLS
5.3.2. HUMAN EMBRYONIC STEM CELLS KITS
5.4. BY APPLICATION
5.4.1. REGENERATIVE MEDICINE & THERAPY DEVELOPMENT
5.4.1.1. ORTHOPEDIC & MUSCULOSKELETAL SPINE STEM CELL ASSAY)
5.4.1.2. DERMATOLOGY STEM CELL
5.4.1.3. CARDIOVASCULAR STEM CELL ASSAY
5.4.1.4. CENTRAL NERVOUS SYSTEM STEM CELL ASSAY
5.4.1.5. ONCOLOGY STEM CELL ASSAY
5.4.2. DRUG DISCOVERY AND DEVELOPMENT
5.4.3. CLINICAL RESEARCH MARKET
5.5. END USER
5.5.1. RESEARCH INSTITUTES
5.5.2. INDUSTRY RESEARCH
6. KEY ANALYTICAL
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.5. STRATEGIC RECOMMENDATION & CONCLUSION
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. EUROPE STEM CELL ASSAY MARKET
7.1.1. UK STEM CELL ASSAY MARKET
7.1.2. FRANCE STEM CELL ASSAY MARKET
7.1.3. GERMANY STEM CELL ASSAY MARKET
7.1.4. SPAIN STEM CELL ASSAY MARKET
7.1.5. ITALY STEM CELL ASSAY MARKET
7.1.6. ROE STEM CELL ASSAY MARKET
8. COMPANY PROFILES
8.1. PROMEGA CORPORATION
8.1.1. OVERVIEW
8.1.2. PRODUCTS PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.1.4. SCOT ANALYSIS
8.1.5. STRATEGIC ANALYSIS
8.2. CELL BIO LABS, INC.
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC ANALYSIS
8.3. GE HEALTHCARE
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.3.4. ANALYSIS
8.4. THERMO FISHER SCIENTIFIC PVT. LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVE
8.4.4. SCOT ANALYSIS
8.4.5. STRATEGIC ANALYSIS
8.5. MERCK MILLIPORE (HOLDING COMPANY IS MERCKKGAA)
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.5.5. STRATEGIC ANALYSIS
8.6. HEMOGENIX INC.
8.6.1. OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC ANALYSIS
8.7. STEMCELL TECHNOLOGIES
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC ANALYSIS
8.8. BIO-RAD
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC ANALYSIS
8.9. R&D SYSTEMS
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. SCOT ANALYSIS
8.9.4. STRATEGIC ANALYSIS
8.10. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.10.4. SCOT ANALYSIS
8.10.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 EUROPE STEM CELL ASSAY MARKET BY TYPES OF ASSAY 2017-2025 ($ MILLION)
TABLE 2 EUROPE STEM CELL ASSAY MARKET BY CELL VIABILITY & TOXICITY ASSAYS 2017-2025 ($ MILLION)
TABLE 3 EUROPE STEM CELL ASSAY MARKET BY ISOLATION/PURIFICATION ASSAYS 2017-2025 ($ MILLION)
TABLE 4 EUROPE STEM CELL ASSAY MARKET BY CELL IDENTIFICATION ASSAYS 2017-2025 ($ MILLION)
TABLE 5 EUROPE STEM CELL ASSAY MARKET IN CELL DIFFERENTIATION ASSAYS 2017-2025 ($ MILLION)
TABLE 6 EUROPE STEM CELL ASSAY MARKET IN CELL FUNCTION ASSAYS 2017-2025 ($ MILLION)
TABLE 7 EUROPE STEM CELL ASSAY MARKET BY CELL APOPTOSIS ASSAYS 2017-2025 ($ MILLION)
TABLE 8 EUROPE STEM CELL ASSAY MARKET BY PRODUCT 2017-2025 ($ MILLION)
TABLE 9 EUROPE STEM CELL ASSAY MARKET BY INSTRUMENTS MARKET 2017-2025 ($ MILLION)
TABLE 10 EUROPE STEM CELL ASSAY MARKET BY DETECTION KITS MARKET 2017-2025 ($ MILLION)
TABLE 11 EUROPE STEM CELL ASSAY MAREKT BY KITS 2017-2025 ($ MILLION)
TABLE 12 EUROPE STEM CELL ASSAY MAREKT BY ADULT STEM CELL KITS 2017-2025 ($ MILLION)
TABLE 13 EUROPE STEM CELL ASSAY MAREKT BY HUMAN EMBRYONIC STEM CELL KITS 2017-2025 ($ MILLION)
TABLE 14 EUROPE STEM CELL ASSSAY MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 15 EUROPE REGENERATIVE AND MEDICINE THARAPY MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 16 EUROPE STEM CELL ASSAY DRUG DISCOVERY APPLICATION MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 17 EUROPE STEM CELL ASSAY CLINICAL RESEARCH MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 18 EUROPE STEM CELL ASSAY MARKET BY END USER 2017-2025($ MILLION)
TABLE 19 RESEARCH ACTIVITIES ON DEIFFERENT TYPE OF STEM CELLS
TABLE 20 EUROPE STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH 2017-2025 ($ MILLION)
TABLE 21 EUROPE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
TABLE 22 CARDIOVASCULAR DISORDERS IN UK IN 2015
FIGURES LIST
FIGURE 1 MARKET SHARE OF INDUSTRY RESEARCH IN STEM CELL ASSAY MARKET 2017-2025 (%)
FIGURE 2 REGENERATIVE MEDICINE & THERAPY DEVELOPMENT BY MARKET SHARE 2016 & 2025 (%)
FIGURE 3 INVESTMENT BY THE PHARMACY MEMBERS IN RESEARCH AND DEVELOPMENT ($ BILLION)
FIGURE 4 INVESTMENT ON STEM CELL RESEARCH BY NIH 2013-2016 ($ BILLION)
FIGURE 5 EUROPE STEM CELL ASSAY MARKET BY HUMAN EMBRYONIC STEM CELLS 2017-2025 ($ MILLION)
FIGURE 6 EUROPE STEM CELL ASSAY APPLICATION MARKET BY REGENERATIVE MEDICINE AND THERAPY 2017-2025 ($ MILLION)
FIGURE 7 EUROPE STEM CELL ASSAY APPLICATION MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2017-2025 ($ MILLION)
FIGURE 8 EUROPE STEM CELL ASSAY APPLICATION MARKET BY CLINICAL RESEARCH 2017-2025 ($ MILLION)
FIGURE 9 EUROPE STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES 2017-2025 ($ MILLION)
FIGURE 10 EUROPE STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH 2017-2025 ($ MILLION)
FIGURE 11 TYPE OF CELL THERAPY IN THE YEAR 2015
FIGURE 12 CAUSES DEATHS UNDER AGE 70 DUE TO NCD’S 2015
FIGURE 13 EUROPE STEM CELL ASSAY MARKET REGIONAL OUTLOOK 2016 & 2025 (IN %)
FIGURE 25 UNITED KINGDOM (UK) STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 26 FRANCE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 27 AGE STRUCTURE OF GERMANY 2015
FIGURE 28 PREVALENCE OF AGING POPULATION ABOVE 65 YEARS 2005 & 2015 (%)
FIGURE 29 GERMANY STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 30 SPAIN STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 31 ITALY STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 32 ROE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. UNITED STATES IS THE FASTEST GROWING STEM CELL ASSAY MARKET
3.2.2. INDUSTRY RESEARCH IS THE LEADING END-USER SEGMENT
3.2.3. DEMAND FOR REGENERATIVE MEDICINE
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. RISING ADOPTION OF STEM CELL ASSAY
4.1.2. IMPROVEMENT IN TECHNOLOGY
4.1.3. SPENDING IN STEM CELL RESEARCH
4.2. MARKET RESTRAINTS
4.2.1. HIGH COST FOR TREATMENT
4.2.2. SLOW RESPONSE TIME OF REGULATORY BODIES
4.3. MARKET OPPORTUNITIES
4.3.1. CHANGING MARKET DYNAMICS
4.4. MARKET CHALLENGES
4.5. ISSUE IN THE PATIENT’S IMMUNE SYSTEM
5. MARKET SEGMENTATION
5.1. BY TYPES OF ASSAY
5.1.1. CELL VIABILITY & TOXICITY ASSAYS
5.1.2. ISOLATION/PURIFICATION ASSAYS
5.1.3. CELL IDENTIFICATION ASSAYS
5.1.4. CELL DIFFERENTIATION ASSAYS
5.1.5. CELL FUNCTION ASSAYS
5.1.6. CELL APOPTOSIS ASSAYS
5.2. BY PRODUCT
5.2.1. INSTRUMENTS
5.2.2. DETECTION KITS
5.3. BY KITS
5.3.1. ADULT STEM CELL KITS
5.3.1.1. MESENCHYMAL STEM CELL KITS
5.3.1.2. INDUCED PLURIPOTENT STEM CELL KITS
5.3.1.3. HEMATOPOIETIC STEM CELL KITS
5.3.1.4. NEURONAL STEM CELLS KITS
5.3.1.5. UMBILICAL CORD STEM CELLS
5.3.2. HUMAN EMBRYONIC STEM CELLS KITS
5.4. BY APPLICATION
5.4.1. REGENERATIVE MEDICINE & THERAPY DEVELOPMENT
5.4.1.1. ORTHOPEDIC & MUSCULOSKELETAL SPINE STEM CELL ASSAY)
5.4.1.2. DERMATOLOGY STEM CELL
5.4.1.3. CARDIOVASCULAR STEM CELL ASSAY
5.4.1.4. CENTRAL NERVOUS SYSTEM STEM CELL ASSAY
5.4.1.5. ONCOLOGY STEM CELL ASSAY
5.4.2. DRUG DISCOVERY AND DEVELOPMENT
5.4.3. CLINICAL RESEARCH MARKET
5.5. END USER
5.5.1. RESEARCH INSTITUTES
5.5.2. INDUSTRY RESEARCH
6. KEY ANALYTICAL
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.5. STRATEGIC RECOMMENDATION & CONCLUSION
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. EUROPE STEM CELL ASSAY MARKET
7.1.1. UK STEM CELL ASSAY MARKET
7.1.2. FRANCE STEM CELL ASSAY MARKET
7.1.3. GERMANY STEM CELL ASSAY MARKET
7.1.4. SPAIN STEM CELL ASSAY MARKET
7.1.5. ITALY STEM CELL ASSAY MARKET
7.1.6. ROE STEM CELL ASSAY MARKET
8. COMPANY PROFILES
8.1. PROMEGA CORPORATION
8.1.1. OVERVIEW
8.1.2. PRODUCTS PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.1.4. SCOT ANALYSIS
8.1.5. STRATEGIC ANALYSIS
8.2. CELL BIO LABS, INC.
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC ANALYSIS
8.3. GE HEALTHCARE
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.3.4. ANALYSIS
8.4. THERMO FISHER SCIENTIFIC PVT. LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVE
8.4.4. SCOT ANALYSIS
8.4.5. STRATEGIC ANALYSIS
8.5. MERCK MILLIPORE (HOLDING COMPANY IS MERCKKGAA)
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.5.5. STRATEGIC ANALYSIS
8.6. HEMOGENIX INC.
8.6.1. OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC ANALYSIS
8.7. STEMCELL TECHNOLOGIES
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC ANALYSIS
8.8. BIO-RAD
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC ANALYSIS
8.9. R&D SYSTEMS
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. SCOT ANALYSIS
8.9.4. STRATEGIC ANALYSIS
8.10. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.10.4. SCOT ANALYSIS
8.10.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 EUROPE STEM CELL ASSAY MARKET BY TYPES OF ASSAY 2017-2025 ($ MILLION)
TABLE 2 EUROPE STEM CELL ASSAY MARKET BY CELL VIABILITY & TOXICITY ASSAYS 2017-2025 ($ MILLION)
TABLE 3 EUROPE STEM CELL ASSAY MARKET BY ISOLATION/PURIFICATION ASSAYS 2017-2025 ($ MILLION)
TABLE 4 EUROPE STEM CELL ASSAY MARKET BY CELL IDENTIFICATION ASSAYS 2017-2025 ($ MILLION)
TABLE 5 EUROPE STEM CELL ASSAY MARKET IN CELL DIFFERENTIATION ASSAYS 2017-2025 ($ MILLION)
TABLE 6 EUROPE STEM CELL ASSAY MARKET IN CELL FUNCTION ASSAYS 2017-2025 ($ MILLION)
TABLE 7 EUROPE STEM CELL ASSAY MARKET BY CELL APOPTOSIS ASSAYS 2017-2025 ($ MILLION)
TABLE 8 EUROPE STEM CELL ASSAY MARKET BY PRODUCT 2017-2025 ($ MILLION)
TABLE 9 EUROPE STEM CELL ASSAY MARKET BY INSTRUMENTS MARKET 2017-2025 ($ MILLION)
TABLE 10 EUROPE STEM CELL ASSAY MARKET BY DETECTION KITS MARKET 2017-2025 ($ MILLION)
TABLE 11 EUROPE STEM CELL ASSAY MAREKT BY KITS 2017-2025 ($ MILLION)
TABLE 12 EUROPE STEM CELL ASSAY MAREKT BY ADULT STEM CELL KITS 2017-2025 ($ MILLION)
TABLE 13 EUROPE STEM CELL ASSAY MAREKT BY HUMAN EMBRYONIC STEM CELL KITS 2017-2025 ($ MILLION)
TABLE 14 EUROPE STEM CELL ASSSAY MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 15 EUROPE REGENERATIVE AND MEDICINE THARAPY MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 16 EUROPE STEM CELL ASSAY DRUG DISCOVERY APPLICATION MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 17 EUROPE STEM CELL ASSAY CLINICAL RESEARCH MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 18 EUROPE STEM CELL ASSAY MARKET BY END USER 2017-2025($ MILLION)
TABLE 19 RESEARCH ACTIVITIES ON DEIFFERENT TYPE OF STEM CELLS
TABLE 20 EUROPE STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH 2017-2025 ($ MILLION)
TABLE 21 EUROPE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
TABLE 22 CARDIOVASCULAR DISORDERS IN UK IN 2015
FIGURES LIST
FIGURE 1 MARKET SHARE OF INDUSTRY RESEARCH IN STEM CELL ASSAY MARKET 2017-2025 (%)
FIGURE 2 REGENERATIVE MEDICINE & THERAPY DEVELOPMENT BY MARKET SHARE 2016 & 2025 (%)
FIGURE 3 INVESTMENT BY THE PHARMACY MEMBERS IN RESEARCH AND DEVELOPMENT ($ BILLION)
FIGURE 4 INVESTMENT ON STEM CELL RESEARCH BY NIH 2013-2016 ($ BILLION)
FIGURE 5 EUROPE STEM CELL ASSAY MARKET BY HUMAN EMBRYONIC STEM CELLS 2017-2025 ($ MILLION)
FIGURE 6 EUROPE STEM CELL ASSAY APPLICATION MARKET BY REGENERATIVE MEDICINE AND THERAPY 2017-2025 ($ MILLION)
FIGURE 7 EUROPE STEM CELL ASSAY APPLICATION MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2017-2025 ($ MILLION)
FIGURE 8 EUROPE STEM CELL ASSAY APPLICATION MARKET BY CLINICAL RESEARCH 2017-2025 ($ MILLION)
FIGURE 9 EUROPE STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES 2017-2025 ($ MILLION)
FIGURE 10 EUROPE STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH 2017-2025 ($ MILLION)
FIGURE 11 TYPE OF CELL THERAPY IN THE YEAR 2015
FIGURE 12 CAUSES DEATHS UNDER AGE 70 DUE TO NCD’S 2015
FIGURE 13 EUROPE STEM CELL ASSAY MARKET REGIONAL OUTLOOK 2016 & 2025 (IN %)
FIGURE 25 UNITED KINGDOM (UK) STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 26 FRANCE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 27 AGE STRUCTURE OF GERMANY 2015
FIGURE 28 PREVALENCE OF AGING POPULATION ABOVE 65 YEARS 2005 & 2015 (%)
FIGURE 29 GERMANY STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 30 SPAIN STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 31 ITALY STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE 32 ROE STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
